Glycemic Outcomes Of Dapagliflozin, Glimepiride, And Sitagliptin As Add-On Therapy To Metformin In Patients With Type 2 Diabetes Mellitus: A Prospective Observational Study. Rev Diabet Stud 2025, 693-700. https://doi.org/10.70082/qs5vrk14.